Current issues in hypertension research and therapy.
Essential hypertension is one of the most common cardiovascular diseases and treatment is based on reducing overall cardiovascular risk. This article reviews current growth areas in hypertension research and practice.
MacFadyen
R J
RJ
Department of Clinical Pharmacology, Ninewells Hospital and Medical School, University of Dundee.
Prasad
N
N
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D001795:Blood Pressure Determination / Q000379:methods; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004032:Diet; D004359:Drug Therapy, Combination; D015444:Exercise; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000503:physiopathology
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D000804:Angiotensin II